The "crosstalk" between gut microbiota, metabolites and genes in diet-induced hepatic steatosis mice intervened with Cordyceps guangdongensis polysaccharides

被引:0
|
作者
Wang, Gangzheng [1 ]
Xie, Bojun [1 ]
Yang, Xinyu [1 ,2 ]
Wang, Ruijuan [3 ]
Zhong, Guorui [1 ]
Gao, Liang [1 ]
Chen, Xiangnv [1 ]
Lin, Min [1 ]
Huang, Qiuju [1 ]
Zhang, Chenghua [1 ]
Huang, Hao [1 ]
Li, Taihui [1 ]
Xu, Jianping [4 ]
Deng, Wangqiu [1 ]
机构
[1] Guangdong Acad Sci, Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect &, State Key Lab Appl Microbiol Southern China, Guangzhou, Peoples R China
[2] Zhongkai Univ Agr & Engn, Coll Agr & Biol, Guangzhou 510225, Peoples R China
[3] Guangdong Acad Agr Sci, Vegetable Res Inst, Guangdong Key Lab New Technol Res Vegetables, Guangzhou 510640, Peoples R China
[4] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada
关键词
Obesity; Cordyceps guangdongensis polysaccharides; Gut microbiota; Bile acid; Lipid metabolism; Carbohydrate metabolism; OBESITY; THERMOGENESIS;
D O I
10.1016/j.ijbiomac.2024.134607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cordyceps guangdongensis, , a novel edible mushroom in China, has shown many positive health effects. In this study, we extracted the C. guangdongensis polysaccharides (CGP) from the fruiting bodies, and investigated the mechanism for CGP improved high-fat diet-induced (HFDI) metabolic diseases. We found that CGP notably reduced fat mass, improved blood lipid levels and hepatic damage, and restored the gut microbiota dysbiosis induced by high-fat diet (HFD). Metabolome analyses showed that CGP changed the composition of bile acids, and regulated HFDI metabolic disorder in hepatic tissue. Transcriptome comparison showed that the improvement of hepatic steatosis for CGP was mainly related to lipid and carbohydrate metabolism. Association analysis result revealed that Odoribacter, , Bifidobacterium and Bi. pseudolongum were negatively correlated to fat and blood lipid indicators, and were significantly associated with genes and metabolites related to carbohydrate and lipid metabolism. Collectively, these results indicate that CGP may be a promising supplement for the treatment of obesity and related metabolic diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Interactions between resveratrol and gut microbiota affect the development of hepatic steatosis: A fecal microbiota transplantation study in high-fat diet mice
    Yin, Xiaohan
    Liao, Weiyao
    Li, Qingrong
    Zhang, Hongmin
    Liu, Zihui
    Zheng, Xinjie
    Zheng, Lin
    Feng, Xiang
    JOURNAL OF FUNCTIONAL FOODS, 2020, 67
  • [42] Dietary γ-Aminobutyric Acid Supplementation Inhibits High-Fat Diet-Induced Hepatic Steatosis via Modulating Gut Microbiota in Broilers
    Chen, Qu
    Hu, Dan
    Wu, Xiaoting
    Feng, Yuyan
    Ni, Yingdong
    MICROORGANISMS, 2022, 10 (07)
  • [43] LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis
    Liu, Bing
    Zhong, Yi
    Huang, Dandan
    Yang, Liuye
    Wang, Pengchao
    Yang, Liu
    Zhang, Fengxiao
    Li, Xiaoguang
    Liang, Minglu
    Huang, Kai
    Du, Meng
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 148
  • [44] Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
    Ting-Chen Chang
    Hao Chiang
    Yu-Heng Lai
    Yu-Ling Huang
    Hsiu-Chen Huang
    Yu-Chih Liang
    Hui-Kang Liu
    Cheng Huang
    BMC Complementary and Alternative Medicine, 19
  • [45] Empagliflozin protects from diet-induced obesity, insulin resistance and hepatic steatosis in mice
    Radlinger, B.
    Ress, C.
    Folie, S.
    Salzmann, K.
    Salvenmoser, W.
    Graber, M.
    Hirsch, J.
    Holfeld, J.
    Kremser, C.
    Moser, P.
    Staudacher, G.
    Jelenik, T.
    Roden, M.
    Tilg, H.
    Kaser, S.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S295 - S295
  • [46] Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
    Bernhard Radlinger
    Claudia Ress
    Sabrina Folie
    Karin Salzmann
    Ana Lechuga
    Bernhard Weiss
    Willi Salvenmoser
    Michael Graber
    Jakob Hirsch
    Johannes Holfeld
    Christian Kremser
    Patrizia Moser
    Gabriele Staudacher
    Tomas Jelenik
    Michael Roden
    Herbert Tilg
    Susanne Kaser
    Diabetologia, 2023, 66 : 754 - 767
  • [47] Sex differences in the development of hepatic steatosis in cafeteria diet-induced obesity in young mice
    Silva Gasparin, Fabiana Rodrigues
    Carreno, Fernando Olinto
    Mewes, Juliana Moraes
    Gilglioni, Eduardo Hideo
    Salgueiro Pagadigorria, Clairce Luzia
    Marcal Natali, Maria Raquel
    Utsunomiya, Karina Sayuri
    Constantin, Rodrigo Polimeni
    Ouchida, Amanda Tomie
    Curti, Carlos
    Gaemers, Ingrid C.
    Johannes Oude Elferink, Ronald Petrus
    Constantin, Jorgete
    Ishii-Iwamoto, Emy Luiza
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (07): : 2495 - 2509
  • [48] INHIBITION OF PLASMINOGEN ACTIVATOR INHIBITOR 1 ATTENUATES DIET-INDUCED HEPATIC STEATOSIS IN MICE
    Henkel, A. S.
    Khan, S.
    Olivares, S.
    Vaughan, D. E.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S673 - S673
  • [49] Metformin Ameliorates Hepatic Steatosis by Suppressing Rhokinase 1 in Diet-Induced Obese Mice
    Lee, Seung-Hwan
    Huang, Hu
    Lima, Ines S.
    Kaneki, Kentaro
    Kim, Young-Bum
    DIABETES, 2013, 62 : A493 - A493
  • [50] Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
    Radlinger, Bernhard
    Ress, Claudia
    Folie, Sabrina
    Salzmann, Karin
    Lechuga, Ana
    Weiss, Bernhard
    Salvenmoser, Willi
    Graber, Michael
    Hirsch, Jakob
    Holfeld, Johannes
    Kremser, Christian
    Moser, Patrizia
    Staudacher, Gabriele
    Jelenik, Tomas
    Roden, Michael
    Tilg, Herbert
    Kaser, Susanne
    DIABETOLOGIA, 2023, 66 (04) : 754 - 767